Vericel Reports 1Q17 Orthobiologic Revenue
Vericel posted 1Q17 orthobiologic revenue of US $5.0MM, -43.2% vs. 1Q16. May 16, 2017
ConforMIS Posts 1Q17 Revenue
ConforMIS posted 1Q17 revenue of US $20.5MM, +1.0% vs. 1Q16. May 16, 2017
Xtant Medical 1Q17 Revenue
Xtant Medical posted 1Q17 revenue of US $22.1MM, +5.3% vs. 1Q16. May 16, 2017
Lima Corporate Expands Shoulder Portfolio, Marks 15 Years with Modular Shoulder
Lima Corporate marked the 15th anniversary of its SMR modular shoulder system with launch of SMR bone graft instruments and Lima Personalized Surgical Instruments. May 16, 2017
Orthonika Secures Funding to Support Synthetic Meniscus Replacement
Orthonika closed a £0.7MM (~US $0.91MM) investment round. Funds will support biomechanical testing and a preclinical pilot trial of MenisciKnit™, a novel synthetic total knee meniscus replacement. May 15, 2017
Exactech Receives FDA Clearance for ExactechGPS Shoulder Application
Exactech received FDA 510(k) clearance to market the ExactechGPS® Shoulder Application. Initial U.S. launch is slated for 2Q17. May 15, 2017
DePuy Synthes Awarded US DOD Contract for Orthopaedic Products
DePuy Synthes was awarded a contract from the U.S. Department of Defense to supply up to US $260MM worth of orthopaedic products to global U.S. military medical facilities. May 15, 2017
Episurf Medical Update: US Regulatory Path
Episurf Medical commenced internal actions to select its regulatory pathway for application for U.S. market acceptance. A decision is expected by 3Q17. May 15, 2017
OrthAlign Receives Japan Approval for Direct Anterior HipAlign and UniAlign
OrthAlign received Japan regulatory approval to market Direct Anterior HipAlign® for use in supine position THA and UniAlign™ for UKA, to be distributed by Zimmer Biomet Japan. May 15, 2017
Curasan Launches CERASORB Ortho Foam in the US
CURASAN entered the U.S. market with the first U.S. implantation of CERASORB® Ortho Foam bone graft. May 15, 2017
